Answers are grounded in this paper and cite their sources.
It was highlighted that there is generally low awareness of or adherence to guidelines in clinical practice and that acid suppression therapy should not be indicated for non-acid reflux, which constitutes a significant proportion of total gastroesophageal reflux episodes among infants. Furthermore, it was emphasised that there is an unmet medical need for therapy for some symptomatic infants with non-acid reflux disease.
No takes yet. Share an insight, caveat, or question.
Vandenplas et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: